# Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.

> **NCT00683865** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 749 (actual)

## Conditions studied

- Pelvic Inflammatory Disease

## Interventions

- **DRUG:** Ofloxacin
- **DRUG:** Avelox (Moxifloxacin, BAY12-8039)

## Key facts

- **NCT ID:** NCT00683865
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 749 (ACTUAL)
- **Last updated:** 2014-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683865, "Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00683865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*